Retatrutide & Muscle: What the DXA Data Really Shows
Viral threads claim GLP-1s strip up to 39% of your weight as muscle and demand a gram of protein per pound. Here is what the controlled body-composition evidence actually supports — and the protein-plus-training plan that protects lean mass on retatrutide.
How It Works
In the SURMOUNT-1 DXA substudy, about 75% of the weight lost was fat and 25% was lean mass — and that fat-to-lean ratio was the same in the placebo group. Losing weight, not the drug itself, is what reduces lean mass.
DXA "lean mass" and BIA "fat-free mass" include water, glycogen, organs and connective tissue. Reviews stress that a drop in lean tissue does not necessarily mean lost strength or physical function.
Guideline-informed targets during GLP-1 weight loss are at least 1.2 g/kg/day (up to about 1.6 g/kg in adults without kidney disease), spread ~0.3–0.4 g/kg per meal with roughly 2.5–3 g of leucine each.
Across 34 randomized trials, adding exercise to calorie restriction preserved about 0.87 kg more fat-free mass — cutting would-be loss by roughly 46%, with mixed and strength training the most effective.
What the Data Shows
Key Takeaways
- In the best-controlled DXA data available (tirzepatide, SURMOUNT-1), about 25% of the weight lost was lean mass — and that share was the same as in the placebo group.
- DXA "lean mass" and BIA "fat-free mass" are not the same as skeletal muscle; they include water, glycogen, organs and connective tissue, so a scan drop does not automatically mean lost strength.
- Protein of at least 1.2 g/kg/day (up to ~1.6 g/kg in adults without kidney disease), spread ~0.3–0.4 g/kg per meal with ~2.5–3 g leucine, is the guideline-informed target for protecting lean tissue.
- Adding resistance or mixed training to calorie restriction prevents roughly 46% of the fat-free mass you would otherwise lose (+0.87 kg across 34 RCTs).
- Retatrutide (LY3437943) is a GIP/GLP-1/glucagon triple agonist; its Phase 2 trial reached about -24% body weight at 48 weeks on the 12 mg dose.
- Older adults, people with sarcopenic obesity, and those with type 2 diabetes are at greatest risk from lean-mass loss and benefit most from a protein-plus-training plan.
- No peer-reviewed DXA body-composition trial of retatrutide has been published yet — viral "first DXA scan data" claims are not from a controlled trial, so retatrutide’s exact fat-to-lean split is still unknown and extrapolated from same-class drugs.
- It is not established that a "1 gram of protein per pound of goal bodyweight" target (~2.2 g/kg) beats the evidence-based ~1.2–1.6 g/kg — the higher intake is a popular heuristic, not a trial-tested requirement.
- Whether the lean mass lost translates into meaningful, lasting loss of strength or physical function for most users is not established.
- Long-term (multi-year) effects of GLP-1-driven lean-mass changes on frailty and sarcopenia risk are still being studied.
Frequently Asked Questions
Does retatrutide cause more muscle loss than other GLP-1 drugs?
There is no published DXA trial of retatrutide yet, so its exact fat-to-lean split is unknown. In the closest comparison — tirzepatide’s SURMOUNT-1 DXA substudy — about 25% of the weight lost was lean mass, the same proportion as diet-only placebo. Any large weight loss reduces lean mass; there is no evidence retatrutide is uniquely worse.
Is 39% of the weight I lose on a GLP-1 really muscle?
That framing overstates it. The best-controlled DXA data put lean-mass loss near 25% of total weight lost, and "lean mass" is not the same as muscle — it also includes water, glycogen and organ tissue. Higher single figures exist but conflate lean mass with skeletal muscle.
How much protein should I eat to keep muscle on retatrutide?
Guideline-informed targets are at least 1.2 g/kg of body weight per day, up to about 1.6 g/kg in adults without kidney disease, spread across meals (~0.3–0.4 g/kg each) with roughly 2.5–3 g of leucine per meal.
Does lifting weights actually preserve muscle during GLP-1 weight loss?
Yes. Across 34 randomized trials, adding resistance or mixed training to calorie restriction preserved about 0.87 kg more fat-free mass — cutting would-be lean-mass loss by roughly 46%. Mixed and strength training worked best.
Should I get a DXA scan while on retatrutide?
DXA (or BIA) is the practical way to track whether you are losing fat versus lean tissue over time. Reviews recommend risk-based body-composition monitoring, especially for older adults and people with type 2 diabetes.
🔬 Research-Grade Source
Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. HighPeptides' primary vendor reference for peptides.
Browse Swiss Chems →Affiliate links — support HighPeptides at no extra cost.
🛒 Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links — support HighPeptides at no extra cost.
📚 Related HighPeptides Research
Peer-Reviewed References
Educational purposes only. Not medical advice.
Retatrutide is an investigational compound not approved by the FDA for weight loss; discuss any medication or body-composition plan with a qualified clinician.